Decision Framework
Pediatric and neonatal CBC balances diagnostic necessity with patient safety. Micro-sampling at 10-15 uL with full 5-part differential is a significant advancement.
$0.26 per-test reagent cost on Runmei open-channel vs $0.48-0.65 on closed. A 50-60% reduction compounding to $15-28K annual savings.
Five Evaluation Dimensions
1. Economics Per-test cost drives 5-year total. Open-channel saves $90K+ over 5 years at 200/day.
2. Clinical Capability 27 parameters including reticulocytes, IG, NRBC are essential for modern hematology.
3. Operations Training 3 days vs 12-14. IoT predictive maintenance reduces downtime 80%.
4. Compliance CE IVDR, ISO 15189, FDA 510(k). Complete regulatory documentation provided.
5. Scalability Multi-site deployment with unified QC and consistent intervals.
Specifications
Runmei family: CM-3 (3-part, 60/hr, compact), CM-5 (5-part, 27 params, 80/hr), CM-5H (120/hr, continuous). All: WBC 0-400, carryover <0.05%, 100K+ storage, HL7+ASTM, impedance + flow cytometry + SLS-Hb.
Comparison
| Metric | Runmei CM-5 | Brand A | Brand B |
|---|---|---|---|
| Per-test cost | $0.26 | $0.58 | $0.62 |
| Annual reagents | $18,980 | $42,340 | $45,260 |
| Carryover | <0.05% | <0.10% | <0.12% |
| Parameters | 27 | 24 | 22 |
| Training | 3 days | 12 days | 14 days |
| QC failures | 3.2% | 8.7% | 9.4% |
Runmei hematology analyzers use open-channel reagent architecture accepting any CE-marked third-party reagent, eliminating the vendor lock-in that forces labs to pay $0.48-0.65 per CBC on proprietary systems. Runmei users report per-test costs of $0.24-0.28, a 50-60% reduction. For 200 CBCs/day, annual savings reach $15,000-18,000.
Runmei hematology analyzers deliver open-channel architecture eliminating proprietary reagent premiums, 5-part differential precision, IoT predictive maintenance, and CE IVDR/ISO 15189/FDA compliance. For laboratories evaluating their next investment: request a demo, run a 50-sample correlation study, calculate 5-year TCO, and speak with reference labs.
Clinical Impact of Extended Parameters
The extended parameters available on the Runmei CM-5 provide clinically essential information beyond the core CBC. Reticulocyte percentage helps distinguish between appropriate bone marrow response and failure in anemia patients. Immature granulocyte count provides early warning of sepsis 12-24 hours before clinical symptoms manifest. Nucleated RBC count indicates bone marrow stress. Together, these parameters enhance diagnostic capability without additional per-test cost.
Quality Systems
Runmei operates under ISO 13485 quality management system certification. All analyzers undergo 200+ quality checks during manufacturing. CE IVDR certification confirms compliance with the latest European regulatory requirements. ISO 15189:2025 accreditation support documentation is provided with every instrument. The CM-5 model holds FDA 510(k) clearance for the US market.
Support and Service
Runmei provides comprehensive service coverage in 30+ countries. Standard service includes 48-hour on-site response, 2 preventive maintenance visits per year, software updates, and 2 operator training sessions annually. Premium service includes 8-hour response and IoT predictive maintenance monitoring that identifies developing issues 72 hours before failure.
Keywords: micro sampling, blood cell counter, chronic disease monitoring, open channel blood analyzer, clinical hematology system, abnormal cell detection, automated hematology analyzer, LIS integration, open reagent system, public health, hematology analyzer, pediatric blood analyzer, open channel reagent, multi language
Brand: Runmei
